{"id":28802,"date":"2023-09-21T09:35:26","date_gmt":"2023-09-21T08:35:26","guid":{"rendered":"https:\/\/cannabishealthnews.co.uk\/?p=28802"},"modified":"2023-09-21T09:40:15","modified_gmt":"2023-09-21T08:40:15","slug":"new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders","status":"publish","type":"post","link":"https:\/\/cannabishealthnews.co.uk\/2023\/09\/21\/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders\/","title":{"rendered":"New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders"},"content":{"rendered":"
A wealth of cannabis-related research has been published over the last few months, including studies examining its potential in the treatment of fibromyalgia<\/a>, autism<\/a> and skin disorders.<\/span><\/p>\n Meanwhile, a review suggests cannabis consumption may be associated with a reduced risk of developing Type 2 diabetes, and a US survey highlights the prevalence of use among cancer<\/a> patients.\u00a0<\/span><\/p>\n We take a closer look.<\/span><\/p>\n In a new study, researchers conducted a retrospective review of patients seeking medicinal cannabis treatment for fibromyalgia between January 2017- July 2021. Data was collected using the Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD-7) scores, and self-reported illness severity.<\/span><\/p>\n According to their findings, a clinically significant reduction in severity was observed in three quarters 75% of patients, as well as reductions in PHQ-9 (27%) and GAD-7 scores (22%).<\/span><\/p>\n The authors conclude: \u201cThese data show that medical cannabis may play an important role in the management of fibromyalgia and associated symptoms of depression and anxiety.\u201d<\/span><\/p>\n Read more here\u00a0<\/a><\/strong><\/p>\n <\/p>\n A new study explored the impact of full-spectrum cannabis extracts in 20 patients with autism spectrum disorders (ASD).<\/span><\/p>\n Most patients were treated for a minimum of six\u2009months, with doses and THC\/CBD levels adjusted depending on results.\u00a0 The researchers used a novel online patient- or caregiver-reported outcome survey to collect information on core and co-morbid symptoms and quality of life.\u00a0<\/span><\/p>\n Their retrospective analysis found that 18 out of 20 patients showed improvement in their symptoms, as well as an improved quality of life for patients and their families.\u00a0<\/span><\/p>\n Side effects were mild and infrequent and <\/span>in most cases, other medications were able to be reduced or discontinued entirely, the researchers say.\u00a0<\/span><\/p>\n Read more about the study here\u00a0<\/a><\/strong><\/p>\n <\/p>\n A new study has suggested that cannabis may have a protective effect against the risk of developing Type 2 diabetes.\u00a0<\/span><\/p>\n To understand more about the effect of cannabis <\/span>on metabolism, including glucose regulation and insulin secretion, r<\/span>esearchers conducted a systematic review of previous studies in this area.\u00a0<\/span><\/p>\n Their meta-analysis of seven studies, containing 11 surveys and four cohort studies, revealed that the odds of developing Type 2 diabetes was\u00a0 0.48 times (95%) lower than in those who had not consumed cannabis.\u00a0<\/span><\/p>\n The authors conclude: \u201cA protective effect of cannabis consumption on the odds of diabetes mellitus type 2 development has been suggested. Yet given the considerable interstudy heterogeneity, the upward trend of cannabis consumption and cannabis legalisation is recommended to conduct studies with higher levels of evidence.\u201d<\/span><\/p>\n Read more about the study here\u00a0<\/a><\/strong><\/p>\n <\/p>\n Results from a survey of over 1,200 cancer patients, show that almost a third used cannabis following their diagnosis.<\/span><\/p>\n Patients with nine different cancers being treated at a centre in the US between March and August 2021 were surveyed on their cannabis use, as well as their attitudes and communication around it.<\/span><\/p>\n Overall 31% used cannabis after diagnosis, ranging from 25% of those with lung cancer to 59% of patients with testicular cancer.\u00a0<\/span><\/p>\n Reasons for cannabis use included difficulty sleeping (48%); stress, anxiety, or depression (46%); and pain (42%), with 70-90% reporting symptom improvement.\u00a0<\/span><\/p>\nCannabis reduces severity of fibromyalgia symptoms\u00a0<\/b><\/h4>\n
Cannabis improves quality of life in autistic patients – and their families\u00a0<\/b><\/h4>\n
Cannabis may reduce risk of developing Type 2 diabetes\u00a0<\/b><\/h4>\n
One third of cancer patients use cannabis – but do their doctors know?<\/b><\/h4>\n